Aurobindo pulls generic Neurontin bottles on empty capsules; Novartis wins European nod for Signifor;


@FiercePharma: UPDATED: NewLink, Merck sign Ebola vaccine licensing pact. More | Follow @FiercePharma

@CarlyHFierce: Marijn Dekkers' tennis partner takes Xarelto. More | Follow @CarlyHFierce

> India's Aurobindo Pharma recalled one lot of gapapentin after empty capsules were found in some bottles. Report

> European regulators gave final approval for the Novartis ($NVS) drug Signifor to treat a rare hormonal disorder called acromegaly, which affects an estimated 10,000 patients in the region. Report

> Novo Nordisk's ($NVO) Victoza won backing from European regulators as a treatment for diabetics with kidney problems, without dose adjustments. Report

> Dr Reddy's Laboratories rolled out its version of the chemotherapy treatment Taxotere in the U.S. Report

> Chinese drug distributor Sinopharm Group is raising about $716 million from a stock sale to expand its wholesale and retail network. Report

Medical Device News

@FierceMedDev: ICYMI Friday: Tandem partners for open-source software to improve insulin pump data access. Story | Follow @FierceMedDev

@EmilyWFierce: #FDA increases safety guidance for power morcellator devices. More | Follow @EmilyWFierce

> Reva raises $25M to get CE mark for bioresorbable scaffold. Story

> FDA approves Avantis Third Eye device for colonoscopies. Article

Biotech News

@FierceBiotech: Lundbeck CEO booted for ethics breach after a biotech's 'gift' comes to light. Article | Follow @FierceBiotech

@JohnCFierce: CAR-T player Juno picks up 'breakthrough' status for lead cancer therapy. Story | Follow @JohnCFierce

@DamianFierce: $BMRN + $RNA sub-question: Does drisapersen qualify for a future rare pediatric disease voucher? | Follow @DamianFierce

> Merck steps into Ebola vaccine race with NewLink rights deal. News

> BioMarin buys Prosensa for up to $840M, shoots for quick OK of Duchenne drug. Article

CRO News

> Parexel recruits NextDocs to its stable of eClinical collaborators. More

> PRA and INC trade up amid a warm reception for CRO debuts. Report

> Medidata and TransCelerate beat the drum for risk-based monitoring. Story

> Feds want more trial results made public. Item

> AMRI gets its desert branch back online after a profit-sapping outage. Article

Biotech IT News

> NCI sees role for feds in validating, processing wearables data. Article

> Novartis VC unit co-leads $53M investment in BioNano Genomics. Story

> Cambrian raises $10M for DNA printing tech used by GSK. News

> NIH cites European precedent in call for disclosure of clinical trial data. Report

> GSK, Medidata report on positive pilot of mHealth in clinical trials. Article

Animal Health News

> Petco boosts animal health presence with purchase of Drs. Foster & Smith. Item

> Are farmed fish contributing to the rise of antibiotic resistance? Article

> Piedmont sets lofty goals for pipeline of 25 veterinary drugs. More

> U.K. launches $3M imaging program to improve pig herd health and production. Story

> Embattled Zoetis courts investors as activist shareholder Ackman looms. Article

And Finally... U.S. trade talks with India, including negotiations involving pharma IP protections, are set to heat up again after national leaders resolved a dispute over global customs reforms. Report